نتایج جستجو برای: inclusion body myositis

تعداد نتایج: 845562  

2002
Sandra Zampieri Anna Ghirardello Katia Rossini Luca Iaccarino Pierfranca Gambari Andrea Doria

Autoimmune response to nuclear and cytoplasmic autoantigens is detected in about 60-80% of patients affected with idiopathic inflammatory myositis such as polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM). Some of the serum autoantibodies are shared with other autoimmune diseases (myositis-associated antibodies MAA) and some of them are unique to myositis (myositis-speci...

Journal: :Rheumatology & autoimmunity 2022

Introduction Statin-associated immune-mediated necrotizing myositis (IMNM) is a rare but distinct idiopathic inflammatory myopathy (IIM) that requires early recognition and intervention to prevent irreversible muscle damage. It typically characterized by active statin use, elevated creatinine kinase (CK) levels, proximal weakness, at times, positive 3-hydroxy-3-methyl-glutaryl-coenzyme A reduct...

Journal: :JAMA 2011
Lisa G Rider Frederick W Miller

The idiopathic inflammatory myopathies or myositis syndromes (the most common forms are polymyositis, dermatomyositis, and inclusion body myositis) are systemic autoimmune diseases defined by chronic muscle weakness and inflammation of unknown etiology and result in significant morbidity and mortality. Research suggests that categorizing heterogeneous myositis syndromes into mutually exclusive ...

2008
Gerald J D Hengstman

3. Information on permissions/orders of reprints rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working in is a monthly international serial edited by Earl D.

Journal: :Statistical applications in genetics and molecular biology 2016
Justina Žurauskienė Paul D W Kirk Michael P H Stumpf

The rapid development of high throughput experimental techniques has resulted in a growing diversity of genomic datasets being produced and requiring analysis. Therefore, it is increasingly being recognized that we can gain deeper understanding about underlying biology by combining the insights obtained from multiple, diverse datasets. Thus we propose a novel scalable computational approach to ...

2016
Jasper M Morrow Christopher D J Sinclair Arne Fischmann Pedro M Machado Mary M Reilly Tarek A Yousry John S Thornton Michael G Hanna

BACKGROUND A substantial impediment to progress in trials of new therapies in neuromuscular disorders is the absence of responsive outcome measures that correlate with patient functional deficits and are sensitive to early disease processes. Irrespective of the primary molecular defect, neuromuscular disorder pathological processes include disturbance of intramuscular water distribution followe...

Journal: :JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2016

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید